“…This new drug trend is particularly diffuse in Eastern European Countries (especially in Russia) (Bersani et al ., ; Vladimirov and Kaimak, ), although recent alerts have also been recorded in Italy, Turkey and Kazakhstan (Bozkurt et al ., ; Prilutskaya and Kuliev, ; Spagnolo et al ., ). According to Vladimirov & Kaimak (), the sales of tropicamide in Russia have increased about 13‐fold over the last 5 years because of its popularity for non‐clinical purposes; similarly, in 2013 the retail sales of tropicamide in Kazakhstan increased of 226% (Prilutskaya and Kuliev, ; Prilutskaya and Kuliev, ).…”